Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial
article
OA: closed
CC0
⤵ 47 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Adenomyosis: Difficult to Diagnose, and Difficult to Treat via openalex
- Adenomyosis: the pathophysiology of an oestrogen-dependent disease via openalex
- A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
- Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma via openalex
- Combination of transvaginal sonography and clinical examination for preoperative diagnosis of pelvic endometriosis via openalex
- Conservative surgical management for diffuse uterine adenomyosis via openalex
- Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest — a dose-ranging study via openalex
- Dienogest via openalex
- Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study via openalex
- Efficacy of Gonadotropin-Releasing Hormone Agonist and an Extended-Interval Dosing Regimen in the Treatment of Patients with Adenomyosis and Endometriosis via openalex
- Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis: a retrospective study via openalex
- Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis via openalex
- MRI of Adenomyosis: Changes with Uterine Artery Embolization via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
- Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest via openalex
- The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis via openalex
- The pharmacological profile of dienogest via openalex
- Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis via openalex
- Treatment of adenomyosis with long-term GnRH analogues: a case report. via openalex
- Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology via openalex
- W2081898822 via openalex
- W2006877767 via openalex
- W2095424038 via openalex
- W2101417341 via openalex
- W2162130706 via openalex
- W1925466818 via openalex
- W159019070 via openalex
- W1997750775 via openalex
- W2046867627 via openalex
- W1963831711 via openalex
- W2080251208 via openalex
Cited by (47)
- Expert Consensus on the Management of Adenomyosis: A Modified Delphi Method Approach by the Taiwan Endometriosis Society 2025
- Risk factors and countermeasures for abnormal uterine bleeding during dienogest therapy for adenomyosis: a review 2025
- Fertility outcome following ovarian stimulation in infertile women having pretreatment with levonorgestrel releasing intrauterine system versus dienogest for symptomatic adenomyosis 2025
- Clinical efficacy of dienogest against endometriomas with a maximum diameter of ≥4 cm 2024
- Effect of dienogest treatment on uterine fibroid volume in patients with endometriosis or adenomyosis complicated by uterine fibroids 2024
- The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis 2024
- The Role of Different Medical Therapies in the Management of Adenomyosis: A Systematic Review and Meta-Analysis 2024
- Contraception et adénomyose 2024
- Adenomyosis 2024
- Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence 2024
- Consider fertility-preserving medications when treating adenomyosis 2024
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
- Efficacy and safety of dienogest versus GnRH-a combined with dienogest therapy for adenomyosis 2023
- Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix 2023
- Adenomyosis in Reproductive Years: Abnormal Uterine Bleeding and Pain 2022
- Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study 2022
- Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review 2022
- Conservative surgical and drug therapies for adenomyosis Medicine 2022
- Clinical practice guidelines for endometriosis in Japan (The 3rd edition) 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Progestins 2022
- Investigation of the 12-month efficacy and safety of low-dose mifepristone in the treatment of painful adenomyosis 2022
- Characterization of patients that can continue conservative treatment for adenomyosis 2021
- Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis 2021
- Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial 2021
- Physiopathologie de l’adénomyose : une énigme non résolue 2021
- Current and Prospective Treatment of Adenomyosis 2021
- Proposal for developing treatment algorithms of women with symptomatic adenomyosis: A single‐center experience 2021
- Characterization of patients that can continue conservative treatment for adenomyosis 2021
- Endometriosis 2020
- Celecoxib, a selective COX‑2 inhibitor, markedly reduced the severity of tamoxifen‑induced adenomyosis in a murine model 2020
- Adenomyosis 2020
- Adenomyosis: clinical aspects, impact on fertility and pregnancy outcome 2020
- Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis 2020
- Current and Future Medical Therapies for Adenomyosis 2020
- [Progress on medical treatment in the management of adenomyosis]. 2019
- Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations 2019
- Pharmacological Treatment for Symptomatic Adenomyosis: A Systematic Review 2019
- Transvaginal ultrasound-guided biopsy of adenomyosis 2019
- Adenomyosis and Infertility 2019
- Long‐term dienogest administration in patients with symptomatic adenomyosis 2018
- Minimally invasive treatment of adenomyosis 2018
- The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility 2018
- Adenomyosis 2017
- Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience 2017
- MicroRNA-17 downregulates expression of the PTEN gene to promote the occurrence and development of adenomyosis 2017
- Current and Future Medical Treatment of Adenomyosis 2016
- Adenomyosis: a systematic review of medical treatment 2016
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:52.213533+00:00
License: CC0
· commercial use OK